Congenital dyserythropoietic anemia type 1 (CDA-1), a rare inborn anemia characterized by abnormal chromatin ultrastructure in erythroblasts, is caused by abnormalities in codanin-1, a highly conserved protein of unknown function. We 
Introduction
The Congenital Dyserythropoietic Anemias (CDAs) are a heterogeneous group of rare inborn disorders mainly affecting erythropoiesis. 1 Distinct from other inherited bone marrow failure syndromes, they are marked by morphological abnormalities of the erythroblasts that lead to ineffective erythropoiesis/dyserythropoiesis, while the other hematopoietic lineages appear to be unaffected. Based largely on the dysplastic changes observed in erythroblasts by light and electron microscopy, the CDAs have been divided into three major types, designated CDA types 1, 2 and 3; 2 causative genes have been identified for CDA-1 (CDAN1/codanin-1) 3 and CDA-2 (CDAN2/Sec23B) 4 , while only the chromosomal locus is known for CDA-3 (15q21-25).
5
In CDA-1, the majority of cases come to attention during childhood and adolescence, often within episodes of erythropoietic stress (i.e infection, and in young women, pregnancy). 6, 7 Severe presentations can include gallstones, chronic hyperbilirubinemia, and/or extramedullary hematopoietic foci in the parietal and frontal bones of the skull (as observed in thalassemia). Although iron overloading is rarely the revelatory sign, it seems to be present in the majority of patients after childhood. In some cases, skeletal or other dysmorphic features can be identified, including short stature, distal limb and nail malformations, vertebral deformations/dysplasias and skin pigmentation defects. 1 The anemia is macrocytic with mean corpuscular volumes (MCV) up to 120 fl, and the blood smear shows anisopoikilocytosis, basophilic stippling and an inadequate reticulocyte response compared to hemolytic anemias. Light microscopy of the bone marrow shows erythroid hyperplasia with abnormal precursors displaying a megaloblastoid appearance. Dysplastic signs include markedly irregular nuclei with frequent (3.5-7%) binucleate erythroblasts (particularly late cells) and occasional tri-and tetranucleate cells. 8 None of these morphological abnormalities are entirely specific for CDA-1 as they can be found in the other CDA types and in other acquired dyserythropoietic states. 9 Particular
For personal use only. on December 27, 2017. by guest www.bloodjournal.org From diagnostic findings in CDA-1 are the presence in the marrow of inter-nuclear bridges between intermediate erythroblasts (~3% of total erythroblasts), and a characteristic pattern of spongy 'Swiss cheese' heterochromatin as observed by electron microscopy. The pattern of inheritance is autosomal recessive and obligate heterozygotes have normal hematological indices, peripheral blood and bone marrow morphology.
A large majority of CDA-1 cases are associated with missense mutations in the CDAN1 gene on chromosome 15q15, leading to single amino-acid substitutions in the 134 kDa codanin-1 protein.
3 A completely null genotype has never been identified in a CDA-1 patient, although rare non-sense mutations can be found in a heterozygous state. Codanin-1 has been evolutionarily highly conserved but its function is still unknown since it carries no previously described peptide motif or domain with similarity to any other within the existing eukaryotic proteome.
Therefore, we examined the consequences of its mutation on chromatin structure in the erythroblasts of CDA-1 patients, and assessed the functional role of Cdan1 in a mouse model.
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Materials and Methods

Patient material, cells and culturing
Subjects were identified through physician-initiated referral and were included in the study based on diagnostic criteria previously described for CDA-1. 
Antibody generation
Sequences from CDAN1 cDNA (obtained from pOTB7 vector; BGDP, USA) encoding large protein fragments (amino acids 294-607 of codanin-1), were cloned into pOPINF vectors, which add a hexa-histidine tag to the N-terminus of the protein, as described by Berrow and colleagues. 13 The protein was produced 
Immunofluorescence and Confocal Microscopy
Cells were allowed to settle on poly-l-lysine-treated coverslips for 10 min. Cells were then fixed in 4% paraformaldehyde (Electron Microscope Services, Fort Washington, PA) for 15 min at RT and permeabilized in 1% Triton X-100 in PBS for 10 min at RT. Non-specific binding sites were blocked using 10% fetal calf serum (PAA Laboratories) in PBS for 30 min at RT. Cells were stained with primary and secondary antibodies in block as listed in Supplementary Table 1, followed by DNA counterstaining with TOPRO-3 (Invitrogen, Paisley, U.K.).
Coverslips were mounted in Vectashield (Vector Laboratories) with 1 μg/mL 4',6-diamidino-2-phenylindole (DAPI, Roche Diagnostics, Mannheim, Germany) added. Analysis of fluorescent preparations was undertaken using a Biorad Radiance 2000 confocal system (Zeiss, Oberkochen, Germany) on a BX51 upright microscope (Olympus, Tokyo, Japan). All images were collected using a 100x NA 1.3 UPlanF1 oil immersion objective (Olympus) at room temperature using LaserSharp software (Zeiss).
X-Gal Staining and Brightfield Microscopy
β-galactosidase staining of cultured cells and of murine embryos was performed after fixation and exposure to X-gal as previously described 14 . TOPRO-3 (Invitrogen) was used as a DNA counterstain. X-gal stained preparations were imaged on a BX60 microscope (Olympus) with a QI CAM CCD camera (Q Imaging, Surrey, Canada) and OpenLab (Improvision, Coventry, England) software.
Electron microscopy
Cell suspensions were fixed in 4% glutaraldehyde in 0.1M phosphate buffer, post-fixed in 2% osmium tetroxide in PBS, dehydrated in ethanol, followed by immersion in propylene oxide prior to embedding in Spurr's epoxy resin. 1 µm sections, stained with Azure A, were examined by light microscopy to identify areas of interest. Thin sections of suitable areas were cut and stained with uranyl acetate and lead citrate prior to examination on a 1200EX electron microscope (JEOL, Tokyo, Japan). Carlsbad, CA) was employed. Proteins were precipitated using chloroformmethanol and re-suspended in 2x Laemmli buffer before immunoblotting as described above. 16 
Protein isolation, SDS-PAGE, immunoblotting and co-immunoprecipitation
Chromatin immunoprecipitation (ChIP)-chip analysis
Antibodies used are described in Supplementary Table 1 . ChIP-chip analysis was perfomed as previously described by De Gobbi and colleagues. 17 Sequences were aligned onto the hg17 assembly using the UCSC Genome Browser (http://genome.ucsc.edu). 18 
DNA Isolation, PCR and Sequencing
DNA was obtained by lysing cells in 10 mM Tris-HCl pH 8.0, 10 mM NaCl, 10 mM EDTA, 0.5% SDS (vol/vol) and 50 g/mL proteinase K (Fermentas International Inc, Burlington, Canada) at a dilution of 5x10 6 cells/mL of buffer at 55°C for 3 h, followed by phenol-chloroform extraction. DNA concentrations were determined using a Nanodrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA).
PCR reactions were performed using Fermentas products (dNTP mix [each 0.25
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RNA Isolation, cDNA Synthesis and RT-PCR and q-PCR
Generating a mouse model
The XG571 murine embryonic stem cell (mESC) clone was obtained from the Chimerae were generated by injection of the XG571 ES cells into CBA/C57BL6
blastocysts and transferred into pseudo-pregnant recipients. Male chimeras were bred to C57/BL6 mice and agouti offspring were genotyped by multiplex PCR.
All animal work was carried out under Home Office UK licence.
Results
Distribution and localization of codanin-1 shown by monoclonal antibody
The study of codanin-1, and its distribution in normal and CDA-1 erythroblasts, has been hampered by the lack of a specific antibody. We have generated the first three monoclonal antibodies against codanin-1, each of a different IgG subclass. These antibodies all identified a single band of the appropriate size 
immunoprecipitated chromatin from CDA-1 erythroblasts and normal controls were hybridized to ENCODE genome-wide microrrays. 22 Representative results of these experiments can be seen in Supplementary Figures 3 and 4. A total of approximately 500 gene loci were examined in detail for the previously studied chromatin marks (H4 acetylation, H3K4 di-methylation (me2), H3K9 trimethylation (me3) and H3K27 tri-methylation (me3)). No significant differences were seen, indicating that the epigenetic landscape is preserved in facultative heterochromatin of erythroblasts in CDA-1.
HP1α distribution in CDA-1
Because of the striking nuclear features displayed by CDA-1 patients'
erythroblasts, we decided to compare the immunofluorescence localization patterns of various nuclear proteins, marking a variety of nuclear subcompartments. No differences were found between patients' and control erythroblasts in the distribution patterns of RNA-polymerase II CTD ser2P (H5), PML, nucleophosmin, HP1β and HP1γ (data not shown). However, the localization of HP1α was found be markedly perturbed in the patients' samples.
As can be seen in Figure 3a 
is abnormal, the quantity of protein present in CDA-1 erythroblasts and EBV-derived lymphoblasts versus controls is at least maintained, if not increased (Figure 3d ).
Our anti-codanin-1 antibodies were found to be unsuitable for immunoprecipitation. However, immunoprecipitation of erythroblast protein extracts with anti-HP1α antibodies co-immunoprecipitated codanin-1 from whole cell extracts but not from nuclear extracts (Figure 4a ). This interaction suggests that an abnormality in codanin-1 could be responsible for the aberrant localization of HP1α.
Codanin-1 and Sec23B co-localize
We found cytoplasmic codanin-1 to localize in a vesicle-like pattern, and in a cellular location suggestive of the ER. We therefore investigated potential links with the vesicular protein involved in the pathogenesis of CDA-2, Sec23B.
Immunoprecipitation with anti-Sec23B antibodies did not clearly co-precipitate codanin-1, suggesting they may not form a direct complex. However, by confocal immunofluorescence, there were clear foci within both the cytoplasm and nucleus of normal erythroblasts where the two co-localize (Figure 4b The ultrastructural phenotype in CDA-1 calls for an investigation of proteins involved in the higher-order structure of chromatin, and of potential consequence on gene regulation in mutants. Surprisingly, no studies of overall chromatin structure analyses in CDA patients have been reported in the literature.
In this study, experiments were performed on cultured erythroblasts of patients with CDA-1. These showed for the first time that the ultrastructural nuclear abnormalities were not associated with either alterations in histone composition nor with changes in modifications of the epigenetic landscape over well-defined gene loci.
The major histone marks were remarkably well maintained in the analyzed regions, including H3K9me3, which has been shown to be crucial in HP1α binding to the nucleosome. 24 One can therefore conclude that epigenetic regulation of the ENCODE contained loci is preserved in CDA-1. Nonetheless, it is important to underline that these genomic areas mainly constitute regions of euchromatin.
More interestingly, we have shown by immunofluorescence that the heterochromatin protein HP1α is sequestered in the Golgi apparatus in primary erythroblasts of patients with CDA-1. Moreover, the nuclear localization pattern of HP1α is abnormal in these cells. Interestingly, these phenomena appeared to be erythroid-specific (i.e. not in CDA-1 EBV-derived lymphoblasts), and were not
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Furthermore, we were able to show the interaction of codanin-1 with HP1α by immunoprecipitation. Additionally, we found that anti-HP1α antibodies coimmunoprecipitate codanin-1 from whole cell but not nuclear erythroblast extracts in CDA-1, and that reduced levels of codanin-1 can be measured in the nuclear fraction of such cells. Altogether, these observations could suggest that HP1α and codanin-1 might not be found in the same complex (or at the same proximity) depending on their nuclear or cytoplasmic location.
These novel findings suggest that codanin-1 mutations may cause CDA-1 via a secondary mechanism involving nuclear HP1α transport. Alternatively, codanin-1 mutations could lead to abnormal HP1α deposition on chromatin and subsequently cause a secondary inappropriate accumulation of HP1α in the Golgi apparatus. Further studies will be required to elucidate this. As a whole, our results suggest that HP1α plays a fundamental role in erythroid maturation.
Perturbations of HP1α, a key player in heterochromatin structure and nuclear organisation 25, 26 , could elegantly explain the ultrastructural phenotype observed in CDA-1 erythroblasts, and these cells' difficulties with cytokinesis. In fact, HP1α has been involved in a wide array of functions, mainly connecting the higherorder structure of chromatin and gene regulation. 24, 26 Interestingly, HP1α also seems to play a role in kinetochore formation and chromosome segregation.
27
HP1α abnormalities could therefore account for the aberrant cytokinesis and the defect in chromatin structure in CDA-1 erythroblasts.
A previous study suggested that codanin-1 expression was restricted to the nucleus and varies with the cell cycle. 28 Differences with the data presented by
Noy-Lotan and colleagues may have resulted from their use of a polyclonal rabbit antibody, whose specificity was not as clearly defined as for our series of murine Cdan1, the β-galactosidase insert provided a useful marker for examining expression of the gene in heterozygotes. We could confirm that Cdan1 is widely expressed in adult mice and that the highest levels can be measured in erythropoietic cells. During development, expression was also widespread with high-levels of Cdan1 found in the digestive tract, the cardio-vascular system and parts of the neuro-epithelium. At a cellular level, we observed that codanin-1 had
For personal use only. on December 27, 2017. by guest www.bloodjournal.org From an identical localization pattern in all examined tissues. Taken as a whole, we were surprised by these observations, and feel they deserve reporting. In fact, although there seems to be no clinically observable gastro-intestinal, cardiovascular or neurological phenotype in patients with CDA-1, we are not aware of any systematic studies in the literature. We feel a very comprehensive and careful work-up of patients with CDA-1 might be required in light of these novel findings.
In summary, our results shed new light onto the function of codanin-1. Our studies show that the absence of this highly conserved ubiquitously expressed protein is embryonic lethal and that mutations responsible for the erythroid specific phenotype act via the abnormal cellular trafficking of the heterochromatin protein HP1α.
23.
van Steensel B, Brink M, van der Meulen K, et al. Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus. Journal of Cell Science. 1995;108:3003-3011.
24.
Lachner 
25.
Eissenberg JC, Elgin SC. The HP1 protein family: getting a grip on chromatin. Curr Opin Genet Dev. 2000;10(2):204-210.
26.
Maison C, Almouzni G. HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol. 2004;5(4):296-304.
27.
Ainsztein AM, Kandels-Lewis SE, Mackay AM, Earnshaw WC. INCENP centromere and spindle targeting: identification of essential conserved motifs and involvement of heterochromatin protein HP1. J Cell Biol. 1998;143(7):1763-1774.
28.
Noy 
31.
Dianzani I, Loreni F. Diamond-Blackfan anemia: a ribosomal puzzle. Haematologica. 2008;93(11):1601-1604.
32.
Fromme JC, Orci L, Schekman R. For
